Hon C. Hui
About
Hon C. Hui is a scholar working on Infectious Diseases, Virology and Epidemiology.
According to data from OpenAlex, Hon C. Hui has authored 25 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 9 papers in Virology and 9 papers in Epidemiology. Recurrent topics in Hon C. Hui's work include HIV/AIDS drug development and treatment (11 papers), HIV Research and Treatment (8 papers) and Blood Coagulation and Thrombosis Mechanisms (5 papers). Hon C. Hui is often cited by papers focused on HIV/AIDS drug development and treatment (11 papers), HIV Research and Treatment (8 papers) and Blood Coagulation and Thrombosis Mechanisms (5 papers). Hon C. Hui collaborates with scholars based in United States, Czechia and Belgium. Hon C. Hui's co-authors include Richard L. Mackman, Tomáš Cihlář, Adrian S. Ray, J. Guy Breitenbucher, Michel Perron, Dustin S. Siegel, Michael O. Clarke, Christine Luong, B.A. Katz and Dinesh V. Patel and has published in prestigious journals such as Journal of Molecular Biology, Scientific Reports and Journal of Medicinal Chemistry.
In The Last Decade
Hon C. Hui
25 papers receiving 1.2k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Hon C. Hui United States | 20 | 580 | 572 | 367 | 226 | 109 | 25 | 1.3k | ||
| Mark W. Stahlhut United States | 21 | 600 1.0× | 656 1.1× | 264 0.7× | 390 1.7× | 252 2.3× | 45 | 1.7k | ||
| T.C. Appleby United States | 22 | 775 1.3× | 361 0.6× | 276 0.8× | 272 1.2× | 65 0.6× | 29 | 1.5k | ||
| Gregory S. Bisacchi United States | 21 | 639 1.1× | 355 0.6× | 763 2.1× | 381 1.7× | 82 0.8× | 35 | 1.7k | ||
| Robert Zahler United States | 25 | 680 1.2× | 352 0.6× | 834 2.3× | 390 1.7× | 130 1.2× | 49 | 1.8k | ||
| Pierre Bonneau Canada | 24 | 677 1.2× | 411 0.7× | 394 1.1× | 279 1.2× | 257 2.4× | 39 | 1.6k | ||
| Suzanne Peyrottes France | 22 | 737 1.3× | 341 0.6× | 505 1.4× | 178 0.8× | 69 0.6× | 94 | 1.5k | ||
| Pierre Raboisson Belgium | 24 | 634 1.1× | 497 0.9× | 555 1.5× | 534 2.4× | 41 0.4× | 60 | 1.8k | ||
| Krzysztof Felczak United States | 20 | 637 1.1× | 306 0.5× | 241 0.7× | 208 0.9× | 56 0.5× | 50 | 1.1k | ||
| Melissa S. Egbertson United States | 20 | 771 1.3× | 664 1.2× | 535 1.5× | 115 0.5× | 564 5.2× | 35 | 1.8k | ||
| Krzysztof W. Pankiewicz United States | 25 | 1.5k 2.5× | 651 1.1× | 611 1.7× | 523 2.3× | 94 0.9× | 97 | 2.3k |
Countries citing papers authored by Hon C. Hui
Since
Specialization
Citations
This map shows the geographic impact of Hon C. Hui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hon C. Hui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hon C. Hui more than expected).
Fields of papers citing papers by Hon C. Hui
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Hon C. Hui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hon C. Hui. The network helps show where Hon C. Hui may publish in the future.
Co-authorship network of co-authors of Hon C. Hui
This figure shows the co-authorship network connecting the top 25 collaborators of Hon C. Hui. A scholar is included among the top collaborators of Hon C. Hui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hon C. Hui. Hon C. Hui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Lo, Michael K., Robert Jordan, Aaron Arvey, et al.. (2017). GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and Paramyxoviruses. Scientific Reports. 7(1). 43395–43395.
2.
Clarke, Michael O., Richard L. Mackman, Daniel Byun, et al.. (2015). Discovery of β-d-2′-deoxy-2′-α-fluoro-4′-α-cyano-5-aza-7,9-dideaza adenosine as a potent nucleoside inhibitor of respiratory syncytial virus with excellent selectivity over mitochondrial RNA and DNA polymerases. Bioorganic & Medicinal Chemistry Letters. 25(12). 2484–2487.
3.
Parrish, Jay P., Constantine G. Boojamra, Hon C. Hui, et al.. (2013). Evaluation of 2′-α-fluorine modified nucleoside phosphonates as potential inhibitors of HCV polymerase. Bioorganic & Medicinal Chemistry Letters. 23(11). 3354–3357.
4.
Liu, H, Lianhong Xu, Hon C. Hui, et al.. (2013). Structure–activity relationships of diamine inhibitors of cytochrome P450 (CYP) 3A as novel pharmacoenhancers, part I: Core region. Bioorganic & Medicinal Chemistry Letters. 24(3). 989–994.
5.
Roethle, Paul A., Ryan M. L. McFadden, Hon C. Hui, et al.. (2013). Identification and Optimization of Pteridinone Toll-like Receptor 7 (TLR7) Agonists for the Oral Treatment of Viral Hepatitis. Journal of Medicinal Chemistry. 56(18). 7324–7333.
6.
Mackman, Richard L., Adrian S. Ray, Hon C. Hui, et al.. (2010). Discovery of GS-9131: Design, synthesis and optimization of amidate prodrugs of the novel nucleoside phosphonate HIV reverse transcriptase (RT) inhibitor GS-9148. Bioorganic & Medicinal Chemistry. 18(10). 3606–3617.
7.
Mackman, Richard L., Constantine G. Boojamra, Lijun Zhang, et al.. (2007). Synthesis, anti-HIV activity, and resistance profiles of ribose modified nucleoside phosphonates. Bioorganic & Medicinal Chemistry Letters. 17(24). 6785–6789.
8.
Mackman, Richard L., Kuei‐Ying Lin, Constantine G. Boojamra, et al.. (2007). Synthesis and anti-HIV activity of 2′-fluorine modified nucleoside phosphonates: Analogs of GS-9148. Bioorganic & Medicinal Chemistry Letters. 18(3). 1116–1119.
9.
Mackman, Richard L., Lijun Zhang, Constantine G. Boojamra, et al.. (2007). Synthesis, anti-HIV activity, and resistance profile of thymidine phosphonomethoxy nucleosides and their bis-isopropyloxymethylcarbonyl (bisPOC) prodrugs. Bioorganic & Medicinal Chemistry. 15(16). 5519–5528.
10.
Mackman, Richard L., Lijun Zhang, Constantine G. Boojamra, et al.. (2007). Synthesis And Anti-Hiv Activity Of Cyclic Pyrimidine Phosphonomethoxy Nucleosides And Their Prodrugs: A Comparison Of Phosphonates And Corresponding Nucleosides. Nucleosides Nucleotides & Nucleic Acids. 26(6-7). 573–577.
11.
Cihlář, Tomáš, Adrian S. Ray, Constantine G. Boojamra, et al.. (2007). Design and Profiling of GS-9148, a Novel Nucleotide Analog Active against Nucleoside-Resistant Variants of Human Immunodeficiency Virus Type 1, and Its Orally Bioavailable Phosphonoamidate Prodrug, GS-9131. Antimicrobial Agents and Chemotherapy. 52(2). 655–665.
12.
Katz, B.A., Kyle Elrod, Erik Verner, et al.. (2003). Elaborate Manifold of Short Hydrogen Bond Arrays Mediating Binding of Active Site-directed Serine Protease Inhibitors. Journal of Molecular Biology. 329(1). 93–120.
13.
Sendzik, Martin & Hon C. Hui. (2003). Environmentally friendly and efficient: iron-mediated reduction of 3-methyl-5-aryl-1,2,4-oxadiazoles to benzamidines. Tetrahedron Letters. 44(48). 8697–8700.
14.
Mackman, Richard L., Hon C. Hui, J. Guy Breitenbucher, et al.. (2002). 2-(2-Hydroxy-3-alkoxyphenyl)-1H-benzimidazole-5-carboxamidine derivatives as potent and selective urokinase-type plasminogen activator inhibitors. Bioorganic & Medicinal Chemistry Letters. 12(15). 2019–2022.
15.
Katz, B.A., Paul A. Sprengeler, Christine Luong, et al.. (2001). Engineering inhibitors highly selective for the S1 sites of Ser190 trypsin-like serine protease drug targets. Chemistry & Biology. 8(11). 1107–1121.
16.
Verner, Erik, B.A. Katz, Jeffrey R. Spencer, et al.. (2001). Development of Serine Protease Inhibitors Displaying a Multicentered Short (<2.3 Å) Hydrogen Bond Binding Mode: Inhibitors of Urokinase-Type Plasminogen Activator and Factor Xa. Journal of Medicinal Chemistry. 44(17). 2753–2771.
17.
Breitenbucher, J. Guy & Hon C. Hui. (1998). Titanium mediated reductive amination on solid support: Extending the utility of the 4-hydroxy-thiophenol linker. Tetrahedron Letters. 39(45). 8207–8210.
18.
Lyttle, Matthew H., et al.. (1994). Isoenzyme-specific glutathione-S-transferase inhibitors: design and synthesis. Journal of Medicinal Chemistry. 37(1). 189–194.
19.
Lyttle, Matthew H., Apparao Satyam, Karin E. Bauer, et al.. (1994). Glutathione-S-transferase Activates Novel Alkylating Agents. Journal of Medicinal Chemistry. 37(10). 1501–1507.
20.
Hui, Hon C., et al.. (1992). Molecular biology of HIV-1 in AIDS dementia complex. Journal of the Neurological Sciences. 113(2). 126–126.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Mark W. Stahlhut Breakdown of academic impact, for papers by T.C. Appleby Breakdown of academic impact, for papers by Gregory S. Bisacchi Breakdown of academic impact, for papers by Robert Zahler Breakdown of academic impact, for papers by Pierre Bonneau Breakdown of academic impact, for papers by Suzanne Peyrottes Breakdown of academic impact, for papers by Pierre Raboisson Breakdown of academic impact, for papers by Krzysztof Felczak Breakdown of academic impact, for papers by Melissa S. Egbertson Breakdown of academic impact, for papers by Krzysztof W. Pankiewicz